Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00170911 | Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis. | PHASE2 | COMPLETED | 160 | — | — | Mar 1, 2005 | - | Nov 2, 2011 | - | — |
| NCT00100607 | Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis | PHASE2 | COMPLETED | 676 | — | — | Feb 1, 2004 | Sep 1, 2005 | May 8, 2012 | - | — |
| Name | Type | Description |
|---|---|---|
| AAE581 | DRUG | - |
Inclusion Criteria: * Low spine Bone Mineral Density * 0 to 1 prevalent fracture in non lumber spine Exclusion Criteria: * History or presence of any bone disease other than osteopenia /osteoporosis * Previous treatment with other anti-osteoporosis agent(Wash out required) * Evidence of vitamin D...
| Company | Ticker | Trials | Lead Phase | Drugs |
|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc. | ZBH | 1 | — | Undisclosed |
| Precision BioSciences, Inc. | DTIL | 1 | NA | Undisclosed |
| SI-BONE, Inc. | SIBN | 1 | — | Undisclosed |